Cancer Survivor Cardiomyopathy Detection
(CASCADE Trial)
SS
TH
Overseen ByTiffany Hansen
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.
Research Team
JH
Joerg Herrmann, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
I was diagnosed with breast cancer, lymphoma, or sarcoma and have completed anthracycline therapy within the past year or more.
I have a history of atrial fibrillation not in remission, even if my latest ECG was normal.
Treatment Details
Interventions
- Echocardiogram
- Electrocardiogram
- NT-pro-BNP
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Prior to anthracycline-based therapyExperimental Treatment3 Interventions
patients presenting before the start of anthracycline-based therapy, then to be followed thereafter for 1 year and thereby contributing to the pool of patients with 1-year post-anthracycline assessment.
Group II: 1 year follow-upExperimental Treatment3 Interventions
patients who were treated in the year before and are now returning for their 1-year follow-up.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Trials
3,427
Recruited
3,221,000+
Miami Heart Research Institute
Collaborator
Trials
2
Recruited
650+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.